- Reaction score
- 129
CRISPR gene-editing tested in a person for the first time
http://www.nature.com/news/crispr-gene-editing-tested-in-a-person-for-the-first-time-1.20988
The rise of CRISPR is certainly exciting, however at this stage we should probably consider just how applicable it is to our circumstances.
Long story short, yes Androgenetic Alopecia is certainly a genetic illness, and CRISPR can indeed fix our genome.
However so far (from what I understand) CRISPR is only being used in vitro (probably because they do not think that it is accurate enough for use in vivo).
At the moment it does look like one way to use CRISPR is to completely knock out the Androgen Receptor gene in all the cells of the scalp. That way just about all the hair you have, and ever will have will be completely immune to the effects of DHT.
But we have to consider the vector. The cas9 and sgRNA need a way to reach the DNA that it is going to knock out.
One option is adeno-associated viruses. This seems pretty standard practice in the field. According to InBeforeTheCure they can be changed in order to only effect a particular cell type. In our case it seems that we would need to target both the epithelial stem cells in the bulge (to protect future hair follicles) and the dermal papilla cells in the dermal papilla (to keep what you've got).
This form of treatment is actually pretty cheap, so there's no reason why you couldn't make one for each stem cell type. The only problem I have with it is that I don't know how specific you can make AAV's, considering that we still want AR's in the rest of our bodies.
https://www.addgene.org/61591/
Another option seems to be liposomes. As Gone pointed out though most studies are quite vague about the effectiveness of liposomes because they don't differentiate between the hair follicle dermal papilla cells or the epithelial cells. In any case Hoffman (2006) seems to think that liposomes were very efficacious and safe to use with gene therapy.
https://www.ncbi.nlm.nih.gov/m/pubmed/9588863/?i=6&from=/11399544/related
For all I know at this point you might be able to target the dermal papilla with the liposomes and then get the epithelial with an AAV.
I'll probably come back a bit later to this, but what do you guys think?
http://www.nature.com/news/crispr-gene-editing-tested-in-a-person-for-the-first-time-1.20988
The rise of CRISPR is certainly exciting, however at this stage we should probably consider just how applicable it is to our circumstances.
Long story short, yes Androgenetic Alopecia is certainly a genetic illness, and CRISPR can indeed fix our genome.
However so far (from what I understand) CRISPR is only being used in vitro (probably because they do not think that it is accurate enough for use in vivo).
At the moment it does look like one way to use CRISPR is to completely knock out the Androgen Receptor gene in all the cells of the scalp. That way just about all the hair you have, and ever will have will be completely immune to the effects of DHT.
But we have to consider the vector. The cas9 and sgRNA need a way to reach the DNA that it is going to knock out.
One option is adeno-associated viruses. This seems pretty standard practice in the field. According to InBeforeTheCure they can be changed in order to only effect a particular cell type. In our case it seems that we would need to target both the epithelial stem cells in the bulge (to protect future hair follicles) and the dermal papilla cells in the dermal papilla (to keep what you've got).
This form of treatment is actually pretty cheap, so there's no reason why you couldn't make one for each stem cell type. The only problem I have with it is that I don't know how specific you can make AAV's, considering that we still want AR's in the rest of our bodies.
https://www.addgene.org/61591/
Another option seems to be liposomes. As Gone pointed out though most studies are quite vague about the effectiveness of liposomes because they don't differentiate between the hair follicle dermal papilla cells or the epithelial cells. In any case Hoffman (2006) seems to think that liposomes were very efficacious and safe to use with gene therapy.
https://www.ncbi.nlm.nih.gov/m/pubmed/9588863/?i=6&from=/11399544/related
For all I know at this point you might be able to target the dermal papilla with the liposomes and then get the epithelial with an AAV.
I'll probably come back a bit later to this, but what do you guys think?